BMY January 2028 Options Begin Trading

The article outlines two options strategies for Bristol Myers Squibb (BMY) stock, currently trading at $46.29, designed for yield generation or discounted share acquisition. Selling a $43.00 strike put for $6.50 offers a potential 15.12% return (6.43% annualized) if it expires worthless, or an effective cost basis of $36.50 if assigned. Alternatively, selling a $47.00 strike covered call for $5.40 could yield a 13.20% total return if the stock is called away, or an 11.67% yield boost (4.96% annualized) if the option expires worthless, with implied volatilities largely consistent with BMY's historical volatility.

Analysis

The options market for Bristol Myers Squibb (BMY), currently trading at $46.29, presents two distinct strategies for yield generation or discounted acquisition. The first strategy involves selling a cash-secured put at the $43.00 strike for a $6.50 premium, which establishes a potential stock acquisition cost basis of $36.50. This represents a 7% discount from the current price to the strike alone. Analytics suggest a 63% probability of this out-of-the-money put expiring worthless, which would translate to a 15.12% return on the cash commitment, or 6.43% annualized. The second strategy is a covered call, selling the $47.00 strike call against existing shares for a $5.40 premium. This could result in a 13.20% total return if the stock is called away by the January 2028 expiration, but caps upside potential above the strike. If the call expires worthless, a scenario with a 45% probability, the investor would realize an 11.67% yield boost (4.96% annualized). The implied volatilities of the put (32%) and call (29%) are closely aligned with the stock's actual trailing twelve-month volatility of 29%, suggesting option premiums are reasonably priced relative to BMY's recent price behavior.

Key Decisions for Investors

• Investors bullish on BMY but seeking a lower entry point could sell the specified cash-secured put to either acquire shares at an effective cost of $36.50 or generate a 6.43% annualized yield.
• Current BMY shareholders with a neutral-to-moderately-bullish outlook might consider the covered call strategy to generate a 4.96% annualized yield boost, accepting a capped total return of 13.20% if the stock is called away at $47.00.
• Given that implied volatility (29-32%) is in line with historical volatility (29%), these strategies appear fairly priced and are not exploiting a volatility arbitrage, but rather are for investors with a defined view on stock price direction and a goal of income generation or discounted acquisition.